Skip to content
Riskpilot
← Back to search
Sign in
Get full access
NOVO NORDISK PHARMA OPERATIONS A/S
A/S
Active
CVR 32657222
Novo Alle 1, 2880
Bagsværd
Intermediation service activities for specialised construction services
· NACE 4360
Est. 2009
— employees
Watchlist
Share
Denmark
/
Companies
/
Intermediation service activities for specialised construction services
/
NOVO NORDISK PHARMA OPERATIONS A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
32M
63M
95M
126M
79M
2020
99M
2021
106M
2022
108M
2023
110M
2024
EBITDA
DKK millions
0M
2M
5M
7M
9M
7M
2020
3M
2021
4M
2022
8M
2023
3M
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Revenue
79.197
98.630
105.720
108.302
109.612
Staff expenses
-0
-0
-0
-0
-0
EBITDA
7.216
2.884
4.131
8.042
3.148
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
7.216
2.884
4.131
8.042
3.148
Net financials
-3.483
1.514
648
-1.277
253
Profit before tax
3.733
4.398
4.779
6.765
3.401
Tax
719
1.243
1.414
1.743
1.103
Net profit
3.014
3.155
3.365
5.022
2.298
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
54.676
70.860
67.875
77.875
87.647
Equity
17.383
20.538
23.903
28.925
31.223
Long-term debt
492
7.829
9.015
13.540
13.379
Short-term debt
36.801
42.493
34.957
35.410
43.045
Total debt
37.293
50.322
43.972
48.950
56.424
Financial ratios
5-year trend
EBITDA margin
2.9%
This company
15.8%
Market median
-82% vs market
2020
2024
Equity ratio
35.6%
This company
38.2%
Market median
+7% vs market
2020
2024
Return on equity
7.4%
This company
18.4%
Market median
-60% vs market
2020
2024
Net profit margin
2.1%
This company
8.1%
Market median
-74% vs market
2020
2024
Asset turnover
1.25×
This company
1.12×
Market median
+12% vs market
2020
2024
Debt / equity
1.81×
This company
0.62×
Market median
-192% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
More on NOVO NORDISK PHARMA OPERATIONS A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
